共 50 条
- [41] Discovery of benzoylisoindolines as a novel class of potent, selective and orally active GlyT1 inhibitorsBIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2010, 20 (23) : 6960 - 6965Pinard, EmmanuelAlberati, DanielaBender, MarkusBorroni, EdilioBrom, VirginieBurner, SergeFischer, HolgerHainzl, DominikHalm, RemyHauser, NicoleJolidon, SyneseLengyel, JudithMarty, Hans-PeterMeyer, ThierryMoreau, Jean-LucMory, RolandNarquizian, RobertNorcross, Roger D.Schmid, PhilippWermuth, RogerZimmerli, Daniel
- [42] Discovery of Pyridopyrimidinones as Potent and Orally Active Dual Inhibitors of PI3K/mTORACS MEDICINAL CHEMISTRY LETTERS, 2018, 9 (03): : 256 - 261Yu, TaoLi, NingWu, ChengdeGuan, AmyLi, YiPeng, ZhengangHe, MiaoLi, JieGong, ZhenHuang, LeiGao, BoHao, DonglingSun, JikuiPan, YanShen, LiangChan, ChichungLu, XiulianYuan, HongyuLi, YongguoLi, JianChen, Shuhui
- [43] The discovery of potent, selective, and orally active pyrazoloquinolines as PDE10A inhibitors for the treatment of SchizophreniaBIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2012, 22 (02) : 1019 - 1022Ho, Ginny D.Yang, Shu-WeiSmotryski, JenniferBercovici, AnaNechuta, TerrySmith, Elizabeth M.McElroy, WilliamTan, ZhengTulshian, DeenMcKittrick, BrianGreenlee, William J.Hruza, AlanXiao, LiRindgen, DianeMullins, DeborraGuzzi, MarioZhang, XiaopingBleickardt, CarinaHodgson, Robert
- [44] Hit-to-Lead in Academia: Discovery of a Protein-Protein Interaction Inhibitor of Keap1-Nrf2YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN, 2018, 138 (08): : 1059 - 1065Yasuda, DaisukeObata, RikaTakahashi, KyokoOhe, TomoyukiMashino, Tadahiko
- [45] MEDI 400-Hit to lead discovery of potent 11b-HSD1 inhibitorsABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2006, 232Kurukulasuriya, RaviYeh, Vince S. C.Chiou, William J.Fung, StevenWang, JiahongSham, Hing L.Link, James T.
- [46] Hit-to-Lead Optimization of the Natural Product Oridonin as Novel NLRP3 Inflammasome Inhibitors with Potent Anti-Inflammation ActivityJOURNAL OF MEDICINAL CHEMISTRY, 2024, 67 (11) : 9406 - 9430He, ChenLiu, JunkaiLi, JundaWu, HongyuJiao, ChenyangZe, XiaotongXu, ShengtaoZhu, ZheyingGuo, WenjieXu, JinyiYao, Hong
- [47] Discovery of Orally Active Hydroxyethylamine Based SPPL2a InhibitorsACS MEDICINAL CHEMISTRY LETTERS, 2019, 10 (06): : 887 - 892Velcicky, JurajMathison, Casey J. N.Nikulin, VictorPflieger, DanielEpple, RobertAzimioara, MihaiCow, ChristopherMichellys, Pierre-YvesRigollier, PascalBeisner, Daniel R.Bodendorf, UrsulaGuerini, DaniloLiu, BoWen, BenZaharevitz, SamanthaBrandl, Trixi
- [48] Preferred Conformation-Guided Discovery of Potent and Orally Active HIF Prolyl Hydroxylase 2 Inhibitors for the Treatment of AnemiaJOURNAL OF MEDICINAL CHEMISTRY, 2023, 66 (13) : 8545 - 8563Wu, YueZhang, LinjianSun, ZhuoliQiu, XushengChen, YafenSu, KaijunYang, LeDu, ZhongqiuDong, YingYang, FulaiLi, XiangZhang, Xiaojin
- [49] Discovery of Potent, Selective, and Orally Active Carboxylic Acid Based Inhibitors of Matrix Metalloproteinase-13JOURNAL OF MEDICINAL CHEMISTRY, 2009, 52 (11) : 3523 - 3538Monovich, Lauren G.Tommasi, Ruben A.Fujimoto, Roger A.Blancuzzi, VincentClark, KirkCornell, Wendy D.Doti, RobertDoughty, JohnFang, JamesFarley, DavidFitt, JohnGanu, VishwasGoldberg, RonaldGoldstein, RobertLavoie, StaceyKulathila, RavirajMacchia, WilliamParker, David T.Melton, RichardO'Byrne, ElizabethPastor, GaryPellas, TheodoreQuadros, ElizabethReel, NoelaRoland, Dennis M.Sakane, YumiSingh, HemSkiles, JerrySomers, JosephToscano, KarenWigg, AndrewZhou, SiyuanZhu, LijuanShieh, Wen-ChungXue, SongMcQuire, Leslie W.
- [50] Discovery of Orally Active, Potent, and Selective Benzotriazole-Based PTP1B InhibitorsCHEMMEDCHEM, 2011, 6 (06) : 1011 - 1016Patel, DipamJain, MukulShah, Shailesh R.Bahekar, RajeshJadav, PradipDarji, BrijeshSiriki, YernaiduBandyopadhyay, DebduttaJoharapurkar, AmitKshirsagar, SamadhanPatel, HarilalShaikh, MubeenSairam, Kalapatapu V. V. M.Patel, Pankaj